106 related articles for article (PubMed ID: 15366955)
1. Adapter protein for site-specific conjugation of payloads for targeted drug delivery.
Backer MV; Gaynutdinov TI; Patel V; Jehning BT; Myshkin E; Backer JM
Bioconjug Chem; 2004; 15(5):1021-9. PubMed ID: 15366955
[TBL] [Abstract][Full Text] [Related]
2. Assembly of targeting complexes driven by a single-chain antibody.
Backer MV; Elliot J; Gaynutdinov TI; Backer JM
J Immunol Methods; 2004 Jun; 289(1-2):37-45. PubMed ID: 15251410
[TBL] [Abstract][Full Text] [Related]
3. Self-assembled "dock and lock" system for linking payloads to targeting proteins.
Backer MV; Patel V; Jehning BT; Backer JM
Bioconjug Chem; 2006; 17(4):912-9. PubMed ID: 16848397
[TBL] [Abstract][Full Text] [Related]
4. Cysteine-containing fusion tag for site-specific conjugation of therapeutic and imaging agents to targeting proteins.
Backer MV; Levashova Z; Levenson R; Blankenberg FG; Backer JM
Methods Mol Biol; 2008; 494():275-94. PubMed ID: 18726580
[TBL] [Abstract][Full Text] [Related]
5. A "dock and lock" approach to preparation of targeted liposomes.
Backer MV; Backer JM
Methods Mol Biol; 2010; 605():257-66. PubMed ID: 20072886
[TBL] [Abstract][Full Text] [Related]
6. Chimeric ribonuclease as a source of human adapter protein for targeted drug delivery.
Gaynutdinov TI; Myshkin E; Backer JM; Backer MV
Protein Eng; 2003 Oct; 16(10):771-5. PubMed ID: 14600207
[TBL] [Abstract][Full Text] [Related]
7. Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor.
Blankenberg FG; Mandl S; Cao YA; O'Connell-Rodwell C; Contag C; Mari C; Gaynutdinov TI; Vanderheyden JL; Backer MV; Backer JM
J Nucl Med; 2004 Aug; 45(8):1373-80. PubMed ID: 15299064
[TBL] [Abstract][Full Text] [Related]
8. An interaction between S*tag and S*protein derived from human ribonuclease 1 allows site-specific conjugation of an enzyme to an antibody for targeted drug delivery.
Asai T; Wims LA; Morrison SL
J Immunol Methods; 2005 Apr; 299(1-2):63-76. PubMed ID: 15914191
[TBL] [Abstract][Full Text] [Related]
9. Humanized docking system for assembly of targeting drug delivery complexes.
Backer MV; Gaynutdinov TI; Gorshkova II; Crouch RJ; Hu T; Aloise R; Arab M; Przekop K; Backer JM
J Control Release; 2003 May; 89(3):499-511. PubMed ID: 12737851
[TBL] [Abstract][Full Text] [Related]
10. Engineering S-protein fragments of bovine ribonuclease A for targeted drug delivery.
Backer MV; Gaynutdinov TI; Aloise R; Przekop K; Backer JM
Protein Expr Purif; 2002 Dec; 26(3):455-61. PubMed ID: 12460770
[TBL] [Abstract][Full Text] [Related]
11. Molecular vehicle for target-mediated delivery of therapeutics and diagnostics.
Gaidamakova EK; Backer MV; Backer JM
J Control Release; 2001 Jul; 74(1-3):341-7. PubMed ID: 11489516
[TBL] [Abstract][Full Text] [Related]
12. A "Dock and Lock" Approach to Preparation of Targeted Liposomes.
Backer MV; Backer JM
Methods Mol Biol; 2017; 1522():83-92. PubMed ID: 27837532
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate.
Torchilin VP
Adv Drug Deliv Rev; 2005 Jan; 57(1):95-109. PubMed ID: 15518923
[TBL] [Abstract][Full Text] [Related]
14. Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries.
Hülsermann U; Hoffmann MM; Massing U; Fricker G
J Drug Target; 2009 Sep; 17(8):610-8. PubMed ID: 19694613
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics-solvated interaction energy studies of protein-protein interactions: the MP1-p14 scaffolding complex.
Cui Q; Sulea T; Schrag JD; Munger C; Hung MN; Naïm M; Cygler M; Purisima EO
J Mol Biol; 2008 Jun; 379(4):787-802. PubMed ID: 18479705
[TBL] [Abstract][Full Text] [Related]
16. Protein photo-cross-linking in mammalian cells by site-specific incorporation of a photoreactive amino acid.
Hino N; Okazaki Y; Kobayashi T; Hayashi A; Sakamoto K; Yokoyama S
Nat Methods; 2005 Mar; 2(3):201-6. PubMed ID: 15782189
[TBL] [Abstract][Full Text] [Related]
17. Construction and characterization of a t-PA mutant for use in ATTEMPTS: a drug delivery system for achieving targeted thrombolysis.
Yang VC; Naik SS; Song H; Dombkowski AA; Crippen G; Liang JF
J Control Release; 2005 Dec; 110(1):164-76. PubMed ID: 16260060
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
19. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility.
Albrecht H; Denardo GL; Denardo SJ
J Immunol Methods; 2006 Mar; 310(1-2):100-16. PubMed ID: 16499921
[TBL] [Abstract][Full Text] [Related]
20. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
Demirgöz D; Garg A; Kokkoli E
Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
